Results 31 to 40 of about 12,213 (202)

Cost-effectiveness of pulse oximetry and integrated management of childhood illness for diagnosing severe pneumonia.

PLOS Global Public Health, 2022
Pneumonia is a major killer of children younger than five years old. In resource constrained health facilities, the capacity to diagnose severe pneumonia is low.
Solomon H Tesfaye, Eskindir Loha, Kjell Arne Johansson, Bernt Lindtjørn   +3 more
doaj   +2 more sources

CD4+/CD8+ T lymphocytes imbalance in children with severe 2009 pandemic influenza A (H1N1) pneumonia [PDF]

Korean Journal of Pediatrics, 2011
PurposeThis study was conducted to investigate the immune responses of children with moderate and severe novel influenza A virus (H1N1) pneumonia, and to compare their clinical and immunological findings with those of control subjects.MethodsThirty-two ...
Ji Eun Kim, Siegfried Bauer, Kyong Suk La, Kee Hyoung Lee, Ji Tae Choung, Kyoung Ho Roh, Chang Kyu Lee, Young Yoo   +7 more
doaj   +1 more source

Epidemiology of Adenovirus Pneumonia and Risk Factors for Bronchiolitis Obliterans in Children During an Outbreak in Jilin, China

Frontiers in Pediatrics, 2021
Background: Jilin Province, located in northeastern China, recently experienced a human adenovirus (HAdV) epidemic. Few studies involving hospitalized pediatric patients with pneumonia caused by HAdV in our region exist. HAdV pneumonia can lead to severe
Xiuhua Yu, Yucong Ma, Yang Gao, Hailong You   +3 more
doaj   +1 more source

Study on the effect of phentolamine combined with vitamins A/D on inflammatory responses and humoral immunity in children with severe pneumonia

Pakistan Journal of Pharmaceutical Sciences
Pneumonia is a common childhood illness that can become life-threatening if it progresses to severe pneumonia. Currently, there are considerable limitations in the diagnosis and treatment of severe pneumonia in clinical practice, which also leads to a ...
Yinfang Li, Dan Xu, Peiling Yin
doaj   +1 more source

Interleukin-40 as a biomarker of mortality risk in patients with severe pneumonia

Frontiers in Immunology
Severe pneumonia is an acute lung parenchyma infectious disease with a high incidence and mortality. The role of interleukin-40 (IL-40) in estimating mortality in patients with severe pneumonia remains unknown.
Hong Tan, Hanyi Wang, Xuanyi Zhou, Jun Duan, Xiaoliang Yang   +4 more
doaj   +1 more source

ETIOLOGICAL FEATURES AND ANTIMICROBIAL RESISTANCE IN HEALTHCARE-ASSOCIATED PNEUMONIA

Arta Medica, 2020
Objectives. Healthcare-associated pneumonia develops in patients undergoing regular medical procedures or has a longterm contact with the hospital environment. Several studies have shown important differences in healthcare-associated pneumonia, comparing
Cristina Toma, Doina Rusu, Victor Botnaru   +2 more
doaj   +1 more source

Prevalence of 21 Physician‐Defined Severe Toxicities Following Childhood Acute Lymphoblastic Leukemia Treatment: Australian Retrospective Cohort Study

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Acute lymphoblastic leukemia (ALL) is the most common pediatric cancer, with an overall survival now surpassing 90% in developed countries. However, treatments are not without adverse effects. In this study, we apply the severe toxicity‐free survival (STFS) framework to determine the prevalence of 21 physician‐defined severe ...
Lane Collier, Brittany Grantham, Camilla Grud Nielsen, Louise Lundgren, Liv Andrés‐Jensen, Kjeld Schmiegelow, Chris Selman, Gareth Ball, Elyse Passmore, David A. Elliott, Rachel Conyers   +10 more
wiley   +1 more source

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: A Comparison With Rituximab

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan, Lei Zhou, Jingzi ZhangBao, Hongmei Tan, Zhouzhou Wang, Chao Quan   +5 more
wiley   +1 more source

Influenza Vaccination Responses in Disabled Stroke Patients: A Single‐Center Prospective Observational Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study aimed to investigate the immunological response to influenza vaccination, the incidence and severity of influenza infection, and the side effects of the vaccination in patients with ischemic stroke. Methods This prospective observational study was conducted between 2023 and 2024 at Ramathibodi Hospital.
Achiraya Pakngao, Sureerat Suwatcharangoon, Pintip Ngamjanyapron, Kobporn Boonnak, Thanitta Suangtamai, Porpon Rotjanapan   +5 more
wiley   +1 more source

Pneumonia Severity Index in the Immunocompromised [PDF]

Canadian Respiratory Journal, 2006
BACKGROUND: The pneumonia severity index (PSI) accounts for many comorbidities, but not immunosuppression.OBJECTIVES: To document the utility of the PSI to predict mortality in immunocompromised patients (IP) with community‐acquired pneumonia (CAP).METHODS: Charts of 284 patients with immunosuppression and CAP were reviewed, and these patients were ...
Sanders, Kevin M, Marras, Theodore K, Chan, Charles KN   +2 more
openaire   +4 more sources